Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TPMT | P51580 | 2/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.40 |
| ▸ | CA12 | O43570 | 2/20 | 0.36 |
| ▸ | CA1 | P00915 | 2/20 | 0.36 |
| ▸ | CA2 | P00918 | 2/20 | 0.36 |
| ▸ | CA7 | P43166 | 2/20 | 0.36 |
| ▸ | CA9 | Q16790 | 2/20 | 0.36 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | DPP4 | P27487 | 1/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | GLA | P06280 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL9787611 | 0.96 | TPMT (0.39) | TPMTCYP1A2CA12CA1CA2 | |
| SCHEMBL8537633 | 0.93 | TPMT (0.38) | TPMTCYP1A2CA12CA1CA2 | |
| SCHEMBL7596897 | 0.92 | TPMT (0.41) | TPMTCYP1A2CA12CA1CA2 | |
| Hydrochloric Acid SCHEMBL8536294 | 0.90 | TPMT (0.36) | TPMTCYP1A2CA12CA1CA2 | |
| SCHEMBL8855992 | 0.89 | TPMT (0.39) | TPMTCYP1A2CA12CA1CA2 | |
| SCHEMBL1859003 | 0.89 | TPMT (0.39) | TPMTCYP1A2CA12CA1CA2 | |
| SCHEMBL9600105 | 0.89 | TPMT (0.39) | TPMTCYP1A2CA12CA1CA2 | |
| Hydrochloric Acid SCHEMBL8541347 | 0.89 | TPMT (0.39) | TPMTCYP1A2CA12CA1CA2 | |
| SCHEMBL5586281 | 0.87 | DPP4 (0.37) | TPMTCYP1A2CA12CA1CA2 | |
| Hydrochloric Acid SCHEMBL8824728 | 0.86 | TPMT (0.38) | TPMTCYP1A2CA12CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 72 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260140444-A1 | PHOTORESIST COMPOSITION AND METHOD OF MANUFACTURING SEMICONDUCTOR DEVICE | TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY, LTD. (TW) | 2026-05-21 | — | — | US | claimed |
| CN-118308893-B | Water-saving polyester cotton printing and dyeing process | 绍兴高温印染有限公司 | 2024-10-25 | — | — | CN | claimed |
| CN-118308893-A | Water-saving polyester cotton printing and dyeing process | 绍兴高温印染有限公司 | 2024-07-09 | — | — | CN | claimed |
| US-7355067-B2 | Process for the production of triiodotrimesic acid | SCHERING AG (DE) | 2008-04-08 | — | — | US | claimed |
| US-20070093674-A1 | Process for the production of triiodotrimesic acid | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2007-04-26 | — | — | US | claimed |
| US-7166740-B2 | Process for the production of triiodotrimesic acid | SCHERING AG (DE) | 2007-01-23 | — | — | US | claimed |
| US-7083516-B2 | Process for the production of triiodotrimesic acid | SCHERING AG (DE) | 2006-08-01 | — | — | US | claimed |
| US-20050113598-A1 | Process for the production of triiodotrimesic acid | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2005-05-26 | — | — | US | claimed |
| US-20050070735-A1 | Process for the production of triiodotrimesic acid | SCHERING AG (DE) | 2005-03-31 | — | — | US | claimed |
| EP-0767779-A1 | ALPHA-(CYCLOALKYL, ARYL AND ARALKYL)SUBSTITUTED POLYIODINATED AROYLOXY COMPOUNDS | NanoSystems L.L.C. (US) | 1997-04-16 | — | — | EP | claimed |
| WO-1996000211-A1 | ALPHA-(CYCLOALKYL, ARYL AND ARALKYL)SUBSTITUTED POLYIODINATED AROYLOXY COMPOUNDS | NANOSYSTEMS L.L.C. (US) | 1996-01-04 | — | — | WO | claimed |
| EP-0032387-B1 | NON IONIC 5-C-SUBSTITUTED 2,4,6-TRIIODO-ISOPHTHALIC ACID DERIVATIVES, PROCESS FOR THEIR PREPARATION AND X-RAY CONTRAST AGENTS CONTAINING THEM | SCHERING AKTIENGESELLSCHAFT (DE) | 1983-11-02 | — | — | EP | claimed |
| US-20260140444-A1 | PHOTORESIST COMPOSITION AND METHOD OF MANUFACTURING SEMICONDUCTOR DEVICE | TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY, LTD. (TW) | 2026-05-21 | — | — | US | disclosed |
| EP-4739355-A1 | CROSSLINKED HYDROGELS WITH ENHANCED RADIOPACITY FOR MEDICAL APPLICATIONS | Boston Scientific Scimed, Inc. (US) | 2026-05-13 | — | — | EP | disclosed |
| US-20260115330-A1 | RADIOPAQUE MULTI-ARM POLYMERS FOR MEDICAL APPLICATIONS | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2026-04-30 | — | — | US | disclosed |
| US-12566374-B2 | Photoresist composition and method of manufacturing semiconductor device | TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY, LTD. (TW) | 2026-03-03 | — | — | US | disclosed |
| WO-1996000211-A1 | ALPHA-(CYCLOALKYL, ARYL AND ARALKYL)SUBSTITUTED POLYIODINATED AROYLOXY COMPOUNDS | NANOSYSTEMS L.L.C. (US) | 1996-01-04 | — | — | WO | disclosed |
| US-5466433-A | X-ray imaging contrast agents | EASTMAN KODAK COMPANY (US) | 1995-11-14 | — | — | US | disclosed |
| US-5047228-A | X-ray contrast; medical diagnosis | SCHERING AKTIENGESELLSCHAFT (DE) | 1991-09-10 | — | — | US | disclosed |
| EP-0033426-A2 | Triiodobenzoyl derivatives useful as non-ionic contrast media and amino-dioxepane intermediates for their synthesis | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1981-08-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260140444-A1 | PHOTORESIST COMPOSITION AND METHOD OF MANUFACTURING SEMICONDUCTOR DEVICE | INO80C, INO80, NAT10 | TPMT 3583/4885CYP1A2 3269/4885CA12 1539/4885 |
| US-20050070735-A1 | Process for the production of triiodotrimesic acid | TRHDE, TRHR, TSHR | TPMT 750/4885CYP1A2 219/4885CA12 570/4885 |
| US-20260115330-A1 | RADIOPAQUE MULTI-ARM POLYMERS FOR MEDICAL APPLICATIONS | KLK3, BRDT, BPHL | TPMT 4080/4885CYP1A2 3809/4885CA12 233/4885 |
| US-20070093674-A1 | Process for the production of triiodotrimesic acid | TRHDE, TRHR, TSHR | TPMT 750/4885CYP1A2 219/4885CA12 570/4885 |
| US-12566374-B2 | Photoresist composition and method of manufacturing semiconductor device | INO80C, INO80, PI4K2B | TPMT 3742/4885CYP1A2 3418/4885CA12 2105/4885 |
| US-20050113598-A1 | Process for the production of triiodotrimesic acid | TRHDE, TRHR, TSHR | TPMT 750/4885CYP1A2 219/4885CA12 570/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.